Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series D for Spine Wave results in $45mm

Executive Summary

Spine Wave (spinal surgery devices) raised $45mm in its Series D financing led by Compass Global Fund (managed by Compass Financial Advisors) with additional participation from individual investors and returning shareholders New Enterprise Associates, Sprout Capital, Canaan Partners, Thoma Cressey Equity Partners, CHL Medical Partners, Morgenthaler Venture Partners, Foundation Medical Partners, and California Technology Partners. Spine Wave brought in a total of $73.75mm in its previous three financing rounds.
Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Rehabilitation Equipment and Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies